Search

everythinglearnresearchcommunity

for

Search:↓

17-β estradiol and prednisolone may speed up hair regrowth after chemotherapy.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Retinol acetate can reduce the harmful effects of the drug benoxaprofen on white blood cells.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Melamax® protects skin from UV damage and reduces inflammation and oxidative stress.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Some breast cancer chemotherapy can cause permanent hair loss.

Melatonin may help prevent hair loss caused by the chemotherapy drug paclitaxel.

Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Drug repurposing offers faster, cheaper drug development but faces challenges like safety, ethics, and funding.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Improving hair health and managing conditions can enhance scalp cooling effectiveness in preventing hair loss during chemotherapy.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Geranyl acetate can protect skin cells from damage and inflammation caused by para-phenylenediamine.

Chemotherapy affects blood vessels in hair follicles, not stem cells, allowing hair regrowth.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Drug repurposing can be cost-effective but needs more testing for safety and effectiveness.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Better awareness of chemotherapy's side effects improves self-care.